---------- Forwarded message ----------
From: Shell Enfesta <mesothelioma77@gmail.com>
Date: Feb 11, 2008 4:53 PM
Subject: Fwd: LegalView's Newest Practice Area Provides Insight Controversy Surrounding Smoking Cessation Drug Chantix (PRWeb)
To: mesothelioma77.mesothelioma03@blogger.com
From: Shell Enfesta <mesothelioma77@gmail.com>
Date: Feb 11, 2008 4:53 PM
Subject: Fwd: LegalView's Newest Practice Area Provides Insight Controversy Surrounding Smoking Cessation Drug Chantix (PRWeb)
To: mesothelioma77.mesothelioma03@blogger.com
---------- Forwarded message ----------
From: Yahoo! News Search Results for mesothelioma <rssfwd@rssfwd.com>
Date: Feb 10, 2008 5:03 PM
Subject: LegalView's Newest Practice Area Provides Insight Controversy Surrounding Smoking Cessation Drug Chantix (PRWeb)
To: mesothelioma77@gmail.com
From: Yahoo! News Search Results for mesothelioma <rssfwd@rssfwd.com>
Date: Feb 10, 2008 5:03 PM
Subject: LegalView's Newest Practice Area Provides Insight Controversy Surrounding Smoking Cessation Drug Chantix (PRWeb)
To: mesothelioma77@gmail.com
LegalView launched a new practice area regarding the controversial drug that is used to help smokers quit, but may be in fact be causing suicidal tendencies and behaviors in patients. (PRWeb Feb 10, 2008) Read the full story at http://www.prweb.com/releases/2008/02/prweb688923.htm
Sun, 10 Feb 2008 08:20:05 GMT
___
Source: http://us.rd.yahoo.com/dailynews/rss/search/mesothelioma/SIG=11pqejlpo/*http%3A//www.prweb.com/releases/2008/02/prweb688923.htm
--
Sun, 10 Feb 2008 08:20:05 GMT
___
Source: http://us.rd.yahoo.com/dailynews/rss/search/mesothelioma/SIG=11pqejlpo/*http%3A//www.prweb.com/releases/2008/02/prweb688923.htm
--
~
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc